[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice

BACKGROUND: Belinostat is a histone deacetylase inhibitor with anti-tumor effect in several pre-clinical tumor models and clinical trials. The aim of the study was to evaluate changes in cell proliferation and glucose uptake by use of 3’-deoxy-3’-[(18)F]fluorothymidine ([18F]FLT) and 2-deoxy-2-[(18)...

詳細記述

保存先:
書誌詳細
主要な著者: Jensen, Mette Munk, Erichsen, Kamille Dumong, Johnbeck, Camilla Bardram, Björkling, Fredrik, Madsen, Jacob, Jensen, Peter Buhl, Sehested, Maxwell, Højgaard, Liselotte, Kjær, Andreas
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3621527/
https://ncbi.nlm.nih.gov/pubmed/23548101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-168
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料